Citation Information :
Nasa P, Majeed NA. Paroxysmal Sympathetic Hyperactivity after Traumatic Brain Injury: Current Understanding and Therapeutic Options. Indian J Crit Care Med 2024; 28 (2):97-99.
Hughes JD, Rabinstein AA. Early diagnosis of paroxysmal sympathetic hyperactivity in the ICU. Neurocritical Care 2014;20(3):454–459. DOI: 10.1007/s12028-013-9877-3.
Baguley IJ, Perkes IE, Fernandez-Ortega JF, Rabinstein AA, Dolce G, Hendricks HT, et al. Paroxysmal sympathetic hyperactivity after acquired brain injury: Consensus on conceptual definition, nomenclature, and diagnostic criteria. J Neurotrauma 2014;31(17): 1515–1520. DOI: 10.1089/neu.2013.3301.
Nasa P. Outcome of hemorrhagic stroke: Host immune response can be a prediction tool! Indian J Crit Care Med 2022;26(1):2–4. DOI: 10.5005/jp-journals-10071-24095.
Perkes I, Baguley IJ, Nott MT, Menon DK. A review of paroxysmal sympathetic hyperactivity after acquired brain injury. Ann Neurol 2010;68(2):126–135. DOI: 10.1002/ana.22066.
Jafari AA, Shah M, Mirmoeeni S, Hassani MS, Nazari S, Fielder T, et al. Paroxysmal sympathetic hyperactivity during traumatic brain injury. Clin Neurol Neurosurg 2022;212:107081. DOI: 10.1016/j.clineuro.2021.107081.
Meyfroidt G, Baguley IJ, Menon DK. Paroxysmal sympathetic hyperactivity: The storm after acute brain injury. Lancet Neurol 2017;16(9):721–729. DOI: 10.1016/S1474-4422(17)30259-4.
Xu SY, Zhang Q, Li CX. Paroxysmal sympathetic hyperactivity after acquired brain injury: An integrative review of diagnostic and management challenges. Neurol Ther 2023. DOI: 10.1007/s40120-023-00561-x.
Alofisan TO, Algarni YA, Alharfi IM, Miller MR, Charyk Stewart T, Fraser DD, et al. Paroxysmal sympathetic hyperactivity after severe traumatic brain injury in children: Prevalence, risk factors, and outcome. Pediatr Crit Care Med 2019;20(3):252–258. DOI: 10.1097/PCC.0000000000001811.
Fernandez-Ortega JF, Baguley IJ, Gates TA, Garcia-Caballero M, Quesada-Garcia JG, Prieto-Palomino MA. Catecholamines and paroxysmal sympathetic hyperactivity after traumatic brain injury. J Neurotrauma 2017;34(1):109–114. DOI: 10.1089/neu.2015.4364.
Mathew MJ, Deepika A, Shukla D, Devi BI, Ramesh VJ. Paroxysmal sympathetic hyperactivity in severe traumatic brain injury. Acta Neurochir (Wien) 2016;158(11):2047–2052. DOI: 10.1007/s00701-016-2934-x.
Lv LQ, Hou LJ, Yu MK, Qi XQ, Chen HR, Chen JX, et al. Prognostic influence and magnetic resonance imaging findings in paroxysmal sympathetic hyperactivity after severe traumatic brain injury. J Neurotrauma 2010;27(11):1945–1950. DOI: 10.1089/neu.2010.1391.
Nguembu S, Meloni M, Endalle G, Dokponou H, Dada OE, Senyuy WP, et al. Paroxysmal sympathetic hyperactivity in moderate-to-severe traumatic brain injury and the role of beta-blockers: A scoping review. Emerg Med Int 2021;2021:5589239. DOI: 10.1155/2021/5589239.
Singh R, Ambasta S, Bais PS, Azim A, Kumar S, Upreti B, et al. Role of gabapentin in traumatic brain injury: A prospective comparative study. Indian J Crit Care Med 2024;28(2):120–125.